In 2008 Shibata et al.42 showed that loss-of-function mutations in Keap1 lead to a rise in chemo-resistance of gallbladder cancer and furthermore inhibition of Nrf2 leads to enhanced sensitivity to 5-fluorouracile treatment. The gene discussed is KEAP1; the disease is gallbladder cancer.